Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
FAYETTEVILLE, Ark. (AP) — Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that improve a patient's immune response against tumors.
The goal of the five-year grant is to help clinicians attack hidden metastatic tumors and prevent cancer recurrence. Metastasis is the development of secondary malignancy away from the primary site of cancer.
David Zaharoff, an assistant professor of biomedical engineering and the principal investigator for the project, says metastasis — not a patient's primary tumor — kills about 90 percent of cancer patients.
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
